PHOJY yields 9.05% · PFE yields 6.13%● Live data
📍 PHOJY pulled ahead of the other in Year 1
Combined, PHOJY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PHOJY + PFE for your $10,000?
Public Joint-Stock Company PhosAgro, together with its subsidiaries, engages in the production and distribution of apatite concentrate and mineral fertilizers in Russia and internationally. It operates in two segments, Phosphate-Based Products and Nitrogen-Based Products. The Phosphate-Based Products segment produces and distributes ammophos, diammoniumphosphate, sodium tripolyphosphate, and other phosphate based and complex fertilizers; and apatite concentrate extracted from the apatite-nepheline ore. The Nitrogen-Based Products segment is involved in the production and distribution of ammonia, ammonium nitrate, and urea. It also offers feed phosphates; phosphate rock; and industrial products, such as syenite alkali aluminum concentrate, titanomagnetite concentrate, nepheline concentrate, aegirine concentrate, oleum, sulphuric acid, sodiumsilicofluoride, aluminum fluoride, nitric acid, and ammonia solution. Public Joint-Stock Company PhosAgro was incorporated in 2001 and is headquartered in Moscow, the Russian Federation.
Full PHOJY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.